0000904454-24-000307.txt : 20240514
0000904454-24-000307.hdr.sgml : 20240514
20240514091628
ACCESSION NUMBER: 0000904454-24-000307
CONFORMED SUBMISSION TYPE: 13F-HR
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240331
FILED AS OF DATE: 20240514
DATE AS OF CHANGE: 20240514
EFFECTIVENESS DATE: 20240514
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Finepoint Capital LP
CENTRAL INDEX KEY: 0001608126
ORGANIZATION NAME:
IRS NUMBER: 462183973
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 13F-HR
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-16580
FILM NUMBER: 24941722
BUSINESS ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 24TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: (617) 336-2200
MAIL ADDRESS:
STREET 1: 500 BOYLSTON STREET
STREET 2: 24TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
13F-HR
1
primary_doc.xml
X0202
13F-HR
LIVE
false
false
false
0001608126
XXXXXXXX
03-31-2024
03-31-2024
false
Finepoint Capital LP
500 Boylston Street
24th Floor
Boston
MA
02116
13F HOLDINGS REPORT
028-16580
000170668
801-79330
N
Stacy L. Vezina
General Counsel
6173362212
/s/ Stacy L. Vezina
Boston
MA
05-14-2024
0
26
389941819
INFORMATION TABLE
2
infotable.xml
ACADIA PHARMACEUTICALS INC
COM
004225108
15539976
840453
SH
SOLE
840453
0
0
ARGENX SE
SPONSORED ADR
04016X101
19686000
50000
SH
SOLE
50000
0
0
ARVINAS INC
COM
04335A105
22254048
539100
SH
SOLE
539100
0
0
ASCENDIS PHARMA A/S
SPONSORED ADR
04351P101
26556336
175672
SH
SOLE
175672
0
0
CALIDI BIOTHERAPEUTICS INC
COM NEW
320703101
70625
125000
SH
SOLE
125000
0
0
CALIDI BIOTHERAPEUTICS INC
*W EXP 03/14/202
320703119
34070
655200
SH
SOLE
655200
0
0
CHURCHILL CAPITAL CORP VII
*W EXP 02/29/202
17144M110
175360
548000
SH
SOLE
548000
0
0
COMPASS DIGITAL ACQUISITION CORP
*W EXP 09/29/202
G2476C123
42311
459906
SH
SOLE
459906
0
0
CONCORD ACQUISITION CORP II
*W EXP 99/99/999
20607U116
45447
408333
SH
SOLE
408333
0
0
CYTOKINETICS INC
COM NEW
23282W605
16689405
238046
SH
SOLE
238046
0
0
DISH NETWORK CORPORATION
NOTE 12/1
25470MAF6
13450500
18300000
PRN
SOLE
18300000
0
0
EYEPOINT PHARMACEUTICALS INC
COM NEW
30233G209
13571922
656600
SH
SOLE
656600
0
0
GALAPAGOS NV
SPON ADR
36315X101
16221040
503759
SH
SOLE
503759
0
0
LIBERTY BROADBAND CORP
COM SER C
530307305
107950660
1886260
SH
SOLE
1886260
0
0
MARBLEGATE ACQUISITION CORP
*W EXP 08/31/202
56608A113
8232
735000
SH
SOLE
735000
0
0
MONEYHERO LIMITED
*W EXP 09/13/202
G6202B119
108474
895000
SH
SOLE
895000
0
0
MOONLAKE IMMUNOTHERAPEUTICS
CLASS A ORD
61559X104
18128811
360916
SH
SOLE
360916
0
0
PROTHENA CORP PLC
SHS
G72800108
9967448
402400
SH
SOLE
402400
0
0
RELAY THERAPEUTICS INC
COM
75943R102
12368411
1490170
SH
SOLE
1490170
0
0
REVOLUTION MEDICINES INC
COM
76155X100
21822933
677100
SH
SOLE
677100
0
0
SAREPTA THERAPEUTICS INC
COM
803607100
20513843
158457
SH
SOLE
158457
0
0
SOLID BIOSCIENCES INC
COM NEW
83422E204
12803863
961251
SH
SOLE
961251
0
0
SPRINGWORKS THERAPEUTICS INC
COM
85205L107
29164228
592528
SH
SOLE
592528
0
0
SWIFTMERGE ACQUISITION CORP
*W EXP 12/13/202
G63836111
27391
490000
SH
SOLE
490000
0
0
TRAVERE THERAPEUTICS INC
COM
89422G107
12715494
1649221
SH
SOLE
1649221
0
0
YS BIOPHARMA CO LTD
*W EXP 03/15/202
G9845F117
24990
489999
SH
SOLE
489999
0
0